Moderna's (NASDAQ: MRNA) success in the coronavirus vaccine race has equaled success for early investors. Let's take a look at how much you would have today if you'd invested $5,000 in Moderna back in 2020. Moderna became one of the first to bring a coronavirus vaccine candidate into clinical trials.